The NCI Division of Cancer Prevention funds new research in cancer prevention, detection, screening, interception, and symptom management. We also fund programs to train people for careers in research. Explore current open funding opportunities here and streamline your search by using keyword or type of funding.
Information about the funding opportunity announcements that align with the efforts of the Cancer MoonshotSM can be found here: https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding.
Notice of Funding Opportunities
Title | Announcement Number | Activity Code | Clinical Trials Status Sort descending | Expiration Date | Program Official |
---|---|---|---|---|---|
Mechanisms that Impact Cancer Risk after Bariatric Surgery | PAR-21-332 (R21 Clinical Trial Not Allowed) | R21 | Clinical Trial Not Allowed | 09/08/2024 | Edward Sauter, M.D., Ph.D. |
HEAL Initiative: Studies to Enable Analgesic Discovery | RFA-NS-25-012 (R61/R33 - Clinical Trial Not Allowed) | R61, R33 | Clinical Trial Not Allowed | 01/16/2027 | Rachel Altshuler, Ph.D. |
HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment | RFA-NS-22-034 (R01 Clinical Trial Not Allowed) | R01 | Clinical Trial Not Allowed | 12/07/2024 | Rachel Altshuler, Ph.D. |
Discovery and Development of Natural Products for Cancer Interception and Prevention | RFA-CA-23-028 (UG3/UH3 Clinical Trial Not Allowed) | UH3, UG3 | Clinical Trial Not Allowed | 06/14/2025 | Altaf Mohammed, Ph.D. |
Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer | PAR-22-061 (R01 Clinical Trial Not Allowed) | R01 | Clinical Trial Not Allowed | 01/08/2025 | Young Kim, Ph.D. |
Basic Research in Cancer Health Disparities | PAR-21-323 (R21 Clinical Trial Not Allowed) | R21 | Clinical Trial Not Allowed | 09/08/2024 | Asad Umar, D.V.M., Ph.D. |
Basic Research in Cancer Health Disparities | PAR-21-324 (R03 Clinical Trial Not Allowed) | R03 | Clinical Trial Not Allowed | 09/08/2024 | Asad Umar, D.V.M., Ph.D. |
Basic Research in Cancer Health Disparities | PAR-21-322 (R01 Clinical Trial Not Allowed) | R01 | Clinical Trial Not Allowed | 09/08/2024 | Asad Umar, D.V.M., Ph.D. |
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics | PAR-23-280 (R21 Clinical Trial Not Allowed) | R21 | Clinical Trial Not Allowed | 01/08/2027 | Edward Sauter, M.D., Ph.D. |
Assay Validation of High Quality Markers for Clinical Studies in Cancer | PAR-23-313 (UH2/UH3 Clinical Trial Not Allowed) | UH2, UH3 | Clinical Trial Not Allowed | 10/15/2026 | Sudhir Srivastava, Ph.D., M.P.H. |